Literature DB >> 25049056

Characterizing the inflammatory tissue response to acute myocardial infarction by clinical multimodality noninvasive imaging.

Tim Wollenweber1, Philipp Roentgen1, Andreas Schäfer1, Imke Schatka1, Caroline Zwadlo1, Thomas Brunkhorst1, Georg Berding1, Johann Bauersachs1, Frank M Bengel2.   

Abstract

BACKGROUND: Myocardial infarction (MI) triggers a systemic inflammatory response which determines subsequent healing. Experimentally, cardiac positron emission tomography and magnetic resonance imaging have been used successfully to obtain mechanistic insights. We explored the translational potential in patients early after MI. METHODS AND
RESULTS: Positron emission tomography/computed tomography and cardiac magnetic resonance were performed in 15 patients <7 days after first MI. Cardiac magnetic resonance showed regional transmural late gadolinium enhancement and edema exceeding the area of late gadolinium enhancement. Using F-18 deoxyglucose with heparin pretreatment, metabolic rate of glucose (MRGlc) was significantly increased in infarct versus remote myocardium (median, 2.0 versus 0.4 mg/min per 100 mL; P=0.0001). MRGlc in infarct correlated with remote myocardium (ρ=0.64; P=0.01), spleen (ρ=0.82; P=0.0002), and bone marrow(ρ=0.57; P=0.03), but not with muscle or liver. Regionally, F-18 deoxyglucose score was highest in segments with late gadolinium enhancement versus edema only and remote (median, 2.0 versus 1.8 versus 0.4; P<0.0001). Patients requiring repeat intervention during preliminary follow-up of 11±5 months tended to have higher early post-MI MRGlc. Five patients with chronic, stable MI served as controls. Opposite to acute MI, MRGlc was lower in infarct (median infarct/remote ratio, 0.6 versus 3.2 for acute MI; P=0.001), and there was no correlation with bone marrow or spleen MRGlc.
CONCLUSIONS: Increased glucose utilization after heparin-induced suppression of myocyte uptake appears to mostly reflect inflammatory activity in damaged myocardium early after MI. Consistent with prior preclinical observations, and in contrast to chronic MI, this is associated with activity in spleen and bone marrow as sources of inflammatory cells. Positron emission tomography and cardiac magnetic resonance multimodality characterization of the acutely infarcted, inflamed myocardium may provide multiparametric end points for clinical studies aiming at support of infarct healing.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  fluorodeoxyglucose F18; inflammation; magnetic resonance imaging; myocardial infarction; positron-emission tomography

Mesh:

Substances:

Year:  2014        PMID: 25049056     DOI: 10.1161/CIRCIMAGING.114.001689

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  36 in total

Review 1.  Advancing biomedical imaging.

Authors:  Ralph Weissleder; Matthias Nahrendorf
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

2.  Relationship between residual viable myocardium and LV remodeling post-MI: Only part of the story.

Authors:  Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2016-02-17       Impact factor: 5.952

3.  Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.

Authors:  Christoph Rischpler; Ralf J Dirschinger; Stephan G Nekolla; Hans Kossmann; Stefania Nicolosi; Franziska Hanus; Sandra van Marwick; Karl P Kunze; Alexander Meinicke; Katharina Götze; Adnan Kastrati; Nicolas Langwieser; Tareq Ibrahim; Matthias Nahrendorf; Markus Schwaiger; Karl-Ludwig Laugwitz
Journal:  Circ Cardiovasc Imaging       Date:  2016-04       Impact factor: 7.792

4.  PET/CT and CMR imaging in a patient with chest pain and unobstructed coronary vessels.

Authors:  Constantinos D Anagnostopoulos; Alexandros Georgakopoulos; Nikoletta Pianou; George Tsirebolos; Stephan G Nekolla; Peter G Danias; Ioannis-Antonios Rizos
Journal:  J Nucl Cardiol       Date:  2015-07-08       Impact factor: 5.952

Review 5.  PET Assessment of Immune Cell Activity and Therapeutic Monitoring Following Myocardial Infarction.

Authors:  James T Thackeray
Journal:  Curr Cardiol Rep       Date:  2018-03-06       Impact factor: 2.931

Review 6.  Hematopoiesis and Cardiovascular Disease.

Authors:  Wolfram C Poller; Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

7.  Diagnostic challenges in infective endocarditis: is PET/CT the solution?

Authors:  Christopher Hohmann; Guido Michels; Matthias Schmidt; Roman Pfister; Navid Mader; Myriam Ohler; Lara Blanke; Nathalie Jazmati; Clara Lehmann; Jan Rybniker; Sarah M Fünger; Gerd Fätkenheuer; Norma Jung
Journal:  Infection       Date:  2019-02-13       Impact factor: 3.553

Review 8.  Clinical imaging of cardiovascular inflammation.

Authors:  Claudia Calcagno; Zahi A Fayad
Journal:  Q J Nucl Med Mol Imaging       Date:  2020-02-18       Impact factor: 2.346

Review 9.  Multiparametric Imaging of Organ System Interfaces.

Authors:  Katrien Vandoorne; Matthias Nahrendorf
Journal:  Circ Cardiovasc Imaging       Date:  2017-04       Impact factor: 7.792

Review 10.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.